
-
Inventiva NASDAQ:IVA
Location: 50 rue de Dijon, Bourgogne Franche Comte, 21121, France | Website: http://inventivapharma.com/ | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
212M
Cash
10.44M
Avg Qtr Burn
-21.18M
Short % of Float
1.51%
Insider Ownership
0.00%
Institutional Own.
6.26%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Lanifibranor (Pan-PPAR) Details Non-alcoholic steatohepatitis , Fatty liver disease, Liver disease | Phase 3 Data readout | |
Lanifibranor + empagliflozin Details Non-alcoholic steatohepatitis , Fatty liver disease, Liver disease, Type 2 diabetes | Phase 2a Update | |
Cedirogant (ABBV-157) (60RORy) Details Psoriasis, Kidney cancer, Carcinoma | Failed Discontinued | |
Odiparcil (GAG) Details Rare diseases, Rare genetic disease, Mucopolysaccharidoses, Mucopolysaccharidosis type IV, Genetic disorder | Failed Discontinued |